158 related articles for article (PubMed ID: 26970271)
1. Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration.
Moradi F; Berglund P; Linnskog R; Leandersson K; Andersson T; Prasad CP
Transl Res; 2016 Jun; 172():45-60. PubMed ID: 26970271
[TBL] [Abstract][Full Text] [Related]
2. Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion.
Jobe NP; Åsberg L; Andersson T
Mol Oncol; 2021 Jul; 15(7):1835-1848. PubMed ID: 33969605
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion.
Linnskog R; Mohapatra P; Moradi F; Prasad CP; Andersson T
Oncotarget; 2016 Jun; 7(25):37790-37802. PubMed ID: 27191257
[TBL] [Abstract][Full Text] [Related]
4. Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
Tang Y; Cao K; Wang Q; Chen J; Liu R; Wang S; Zhou J; Xie H
Oncol Rep; 2016 May; 35(5):2907-15. PubMed ID: 26934938
[TBL] [Abstract][Full Text] [Related]
5. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.
Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ
Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490
[TBL] [Abstract][Full Text] [Related]
6. MiR-4458/human antigen R (HuR) modulates PBX3 mRNA stability in melanoma tumorigenesis.
Zhou H; Rao Y; Sun Q; Liu Y; Zhou X; Chen Y; Chen J
Arch Dermatol Res; 2020 Nov; 312(9):665-673. PubMed ID: 32157373
[TBL] [Abstract][Full Text] [Related]
7. Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.
Blanco FF; Preet R; Aguado A; Vishwakarma V; Stevens LE; Vyas A; Padhye S; Xu L; Weir SJ; Anant S; Meisner-Kober N; Brody JR; Dixon DA
Oncotarget; 2016 Nov; 7(45):74043-74058. PubMed ID: 27677075
[TBL] [Abstract][Full Text] [Related]
8. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
Zhang Z; Huang A; Zhang A; Zhou C
Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.
Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF
J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484
[TBL] [Abstract][Full Text] [Related]
10. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
[TBL] [Abstract][Full Text] [Related]
11. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
Linnskog R; Jönsson G; Axelsson L; Prasad CP; Andersson T
Mol Oncol; 2014 Dec; 8(8):1365-78. PubMed ID: 24954857
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanoma.
Merat R; Bugi-Marteyn A; Wrobel LJ; Py C; Daali Y; Schwärzler C; Liaudet N
Biochem Biophys Res Commun; 2019 Sep; 517(2):181-187. PubMed ID: 31279529
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
Xu W; Chen C; Xu R; Li Y; Hu R; Li Z; Zhu X
Biomed Pharmacother; 2018 Jun; 102():587-593. PubMed ID: 29597092
[TBL] [Abstract][Full Text] [Related]
15. Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.
Baldan F; Mio C; Allegri L; Conzatti K; Toffoletto B; Puppin C; Radovic S; Vascotto C; Russo D; Di Loreto C; Damante G
Oncotarget; 2016 Sep; 7(39):63388-63407. PubMed ID: 27542231
[TBL] [Abstract][Full Text] [Related]
16. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
Ekström EJ; Sherwood V; Andersson T
PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
[TBL] [Abstract][Full Text] [Related]
17. HuR translocation to the cytoplasm of cancer cells in actin-independent manner.
Habiba U; Kuroshima T; Yanagawa-Matsuda A; Kitamura T; Chowdhury A; Jehung JP; Hossain E; Sano H; Kitagawa Y; Shindoh M; Higashino F
Exp Cell Res; 2018 Aug; 369(2):218-225. PubMed ID: 29807023
[TBL] [Abstract][Full Text] [Related]
18. Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.
D'Agostino VG; Lal P; Mantelli B; Tiedje C; Zucal C; Thongon N; Gaestel M; Latorre E; Marinelli L; Seneci P; Amadio M; Provenzani A
Sci Rep; 2015 Nov; 5():16478. PubMed ID: 26553968
[TBL] [Abstract][Full Text] [Related]
19. Loss of Scribble Promotes Snail Translation through Translocation of HuR and Enhances Cancer Drug Resistance.
Zhou Y; Chang R; Ji W; Wang N; Qi M; Xu Y; Guo J; Zhan L
J Biol Chem; 2016 Jan; 291(1):291-302. PubMed ID: 26527679
[TBL] [Abstract][Full Text] [Related]
20. WNT5A: a motility-promoting factor in Hodgkin lymphoma.
Linke F; Zaunig S; Nietert MM; von Bonin F; Lutz S; Dullin C; Janovská P; Beissbarth T; Alves F; Klapper W; Bryja V; Pukrop T; Trümper L; Wilting J; Kube D
Oncogene; 2017 Jan; 36(1):13-23. PubMed ID: 27270428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
